ID   C11B1_RAT               Reviewed;         499 AA.
AC   P15393; Q64655;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   24-JUL-2024, entry version 163.
DE   RecName: Full=Cytochrome P450 11B1, mitochondrial;
DE   AltName: Full=CYPXIB1;
DE   AltName: Full=Cytochrome P450(11 beta)-DS;
DE   AltName: Full=Cytochrome P450C11;
DE   AltName: Full=Steroid 11-beta-hydroxylase, CYP11B1 {ECO:0000250|UniProtKB:P15538};
DE            EC=1.14.15.4 {ECO:0000250|UniProtKB:P15538};
DE   Flags: Precursor;
GN   Name=Cyp11b1; Synonyms=Cyp11b-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2551730; DOI=10.1016/0014-5793(89)81053-1;
RA   Nonaka Y., Matsukawa N., Morohashi K., Omura T., Ogihara T., Teraoka H.,
RA   Okamoto M.;
RT   "Molecular cloning and sequence analysis of cDNA encoding rat adrenal
RT   cytochrome P-450(11)beta.";
RL   FEBS Lett. 255:21-26(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Dahl salt-resistant; TISSUE=Adrenal gland;
RX   PubMed=8473350; DOI=10.1016/s0021-9258(18)52985-9;
RA   Matsukawa N., Nonaka Y., Higaki J., Nagano M., Mikami H., Ogihara T.,
RA   Okamoto M.;
RT   "Dahl's salt-resistant normotensive rat has mutations in cytochrome P450(11
RT   beta), but the salt-sensitive hypertensive rat does not.";
RL   J. Biol. Chem. 268:9117-9121(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=8473352; DOI=10.1016/s0021-9258(18)52987-2;
RA   Mukai K., Imai M., Shimada H., Ishimura Y.;
RT   "Isolation and characterization of rat CYP11B genes involved in late steps
RT   of mineralo- and glucocorticoid syntheses.";
RL   J. Biol. Chem. 268:9130-9137(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=8468320; DOI=10.1093/oxfordjournals.jbchem.a124018;
RA   Nomura M., Morohashi K., Kirita S., Nonaka Y., Okamoto M., Nawata H.,
RA   Omura T.;
RT   "Three forms of rat CYP11B genes: 11 beta-hydroxylase gene, aldosterone
RT   synthase gene, and a novel gene.";
RL   J. Biochem. 113:144-152(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=Dahl salt-resistant;
RX   PubMed=7626522; DOI=10.1016/0960-0760(95)00025-u;
RA   Okamoto M., Nonaka Y., Ohta M., Takemori H., Halder S.K., Zhi-Nong W.,
RA   Sun T., Hatano O., Takakusa A., Murakami T.;
RT   "Cytochrome P450(11 beta): structure-function relationship of the enzyme
RT   and its involvement in blood pressure regulation.";
RL   J. Steroid Biochem. Mol. Biol. 53:89-94(1995).
RN   [6]
RP   PROTEIN SEQUENCE OF 25-44, FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Adrenal cortex;
RX   PubMed=2738055; DOI=10.1016/s0021-9258(18)60408-9;
RA   Ogishima T., Mitani F., Ishimura Y.;
RT   "Isolation of aldosterone synthase cytochrome P-450 from zona glomerulosa
RT   mitochondria of rat adrenal cortex.";
RL   J. Biol. Chem. 264:10935-10938(1989).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1765101; DOI=10.1111/j.1432-1033.1991.tb16449.x;
RA   Nonaka Y., Okamoto M.;
RT   "Functional expression of the cDNAs encoding rat 11 beta-hydroxylase
RT   [cytochrome P450(11 beta)] and aldosterone synthase [cytochrome P450(11
RT   beta, aldo)].";
RL   Eur. J. Biochem. 202:897-902(1991).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1562515; DOI=10.1016/0960-0760(92)90367-r;
RA   Okamoto M., Nonaka Y.;
RT   "Molecular biology of rat steroid 11 beta-hydroxylase [P450(11 beta)] and
RT   aldosterone synthase [P450(11 beta, aldo)].";
RL   J. Steroid Biochem. Mol. Biol. 41:415-419(1992).
CC   -!- FUNCTION: A cytochrome P450 monooxygenase involved in the biosynthesis
CC       of adrenal corticoids (PubMed:1562515, PubMed:1765101, PubMed:2738055).
CC       Catalyzes a variety of reactions that are essential for many species,
CC       including detoxification, defense, and the formation of endogenous
CC       chemicals like steroid hormones (By similarity). Steroid 11beta,
CC       18- and 19-hydroxylase with preferred regioselectivity at 11beta, then
CC       18, and lastly 19 (PubMed:1562515, PubMed:1765101). Catalyzes the
CC       hydroxylation of 11-deoxycortisol and 11-deoxycorticosterone (21-
CC       hydroxyprogesterone) at 11beta position, yielding cortisol or
CC       corticosterone, respectively, but cannot produce aldosterone
CC       (PubMed:1562515, PubMed:1765101, PubMed:2738055). Mechanistically, uses
CC       molecular oxygen inserting one oxygen atom into a substrate for
CC       hydroxylation and reducing the second into a water molecule. Two
CC       electrons are provided by NADPH via a two-protein mitochondrial
CC       transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin
CC       reductase) and nonheme iron-sulfur protein FDX1 or FDX2
CC       (adrenodoxin/ferredoxin). Due to its lack of 18-oxidation activity, it
CC       is incapable of generating aldosterone. Could also be involved in the
CC       androgen metabolic pathway (By similarity).
CC       {ECO:0000250|UniProtKB:P15538, ECO:0000269|PubMed:1562515,
CC       ECO:0000269|PubMed:1765101, ECO:0000269|PubMed:2738055}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a steroid + 2 H(+) + O2 + 2 reduced [adrenodoxin] = an 11beta-
CC         hydroxysteroid + H2O + 2 oxidized [adrenodoxin];
CC         Xref=Rhea:RHEA:15629, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:35341,
CC         ChEBI:CHEBI:35346; EC=1.14.15.4;
CC         Evidence={ECO:0000269|PubMed:1562515, ECO:0000269|PubMed:1765101,
CC         ECO:0000269|PubMed:2738055};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15630;
CC         Evidence={ECO:0000305|PubMed:1562515, ECO:0000305|PubMed:1765101,
CC         ECO:0000305|PubMed:2738055};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=21-hydroxyprogesterone + 2 H(+) + O2 + 2 reduced [adrenodoxin]
CC         = corticosterone + H2O + 2 oxidized [adrenodoxin];
CC         Xref=Rhea:RHEA:46104, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16827, ChEBI:CHEBI:16973, ChEBI:CHEBI:33737,
CC         ChEBI:CHEBI:33738; Evidence={ECO:0000269|PubMed:1562515,
CC         ECO:0000269|PubMed:1765101, ECO:0000269|PubMed:2738055};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46105;
CC         Evidence={ECO:0000305|PubMed:1562515, ECO:0000305|PubMed:1765101,
CC         ECO:0000305|PubMed:2738055};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=21-hydroxyprogesterone + 2 H(+) + O2 + 2 reduced [adrenodoxin]
CC         = 18-hydroxy-11-deoxycorticosterone + H2O + 2 oxidized [adrenodoxin];
CC         Xref=Rhea:RHEA:76151, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16973, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738,
CC         ChEBI:CHEBI:195166; Evidence={ECO:0000269|PubMed:1562515,
CC         ECO:0000269|PubMed:2738055};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76152;
CC         Evidence={ECO:0000305|PubMed:1562515, ECO:0000305|PubMed:2738055};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=21-hydroxyprogesterone + 2 H(+) + O2 + 2 reduced [adrenodoxin]
CC         = 19-hydroxy-11-deoxycorticosterone + H2O + 2 oxidized [adrenodoxin];
CC         Xref=Rhea:RHEA:76155, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16973, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738,
CC         ChEBI:CHEBI:195167; Evidence={ECO:0000269|PubMed:1562515,
CC         ECO:0000269|PubMed:1765101};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76156;
CC         Evidence={ECO:0000305|PubMed:1562515, ECO:0000305|PubMed:1765101};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11-deoxycortisol + 2 H(+) + O2 + 2 reduced [adrenodoxin] =
CC         cortisol + H2O + 2 oxidized [adrenodoxin]; Xref=Rhea:RHEA:46100,
CC         Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17650,
CC         ChEBI:CHEBI:28324, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738;
CC         Evidence={ECO:0000269|PubMed:1562515};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46101;
CC         Evidence={ECO:0000305|PubMed:1562515};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cortisol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = 18-
CC         hydroxycortisol + H2O + 2 oxidized [adrenodoxin];
CC         Xref=Rhea:RHEA:76019, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:17650, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738,
CC         ChEBI:CHEBI:89455; Evidence={ECO:0000305|PubMed:1562515};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76020;
CC         Evidence={ECO:0000305|PubMed:1562515};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11-deoxycortisol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = 18-
CC         hydroxy-11-deoxycortisol + H2O + 2 oxidized [adrenodoxin];
CC         Xref=Rhea:RHEA:76163, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:28324, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738,
CC         ChEBI:CHEBI:195179; Evidence={ECO:0000269|PubMed:1562515};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76164;
CC         Evidence={ECO:0000305|PubMed:1562515};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P19099};
CC   -!- PATHWAY: Steroid biosynthesis; glucocorticoid biosynthesis.
CC       {ECO:0000250|UniProtKB:P15538}.
CC   -!- PATHWAY: Steroid hormone biosynthesis. {ECO:0000250|UniProtKB:P15538}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:P14137}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P14137}.
CC   -!- TISSUE SPECIFICITY: Adrenal zona fasciculata/reticularis.
CC       {ECO:0000269|PubMed:2738055}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D11354; BAA01957.1; -; mRNA.
DR   EMBL; D14091; BAA03171.1; -; Genomic_DNA.
DR   EMBL; X15431; CAA33472.1; -; mRNA.
DR   EMBL; D10107; BAA00988.1; -; mRNA.
DR   PIR; A46039; A46039.
DR   AlphaFoldDB; P15393; -.
DR   SMR; P15393; -.
DR   BindingDB; P15393; -.
DR   ChEMBL; CHEMBL4970; -.
DR   DrugCentral; P15393; -.
DR   PhosphoSitePlus; P15393; -.
DR   PaxDb; 10116-ENSRNOP00000035538; -.
DR   UCSC; RGD:2453; rat.
DR   AGR; RGD:2453; -.
DR   RGD; 2453; Cyp11b1.
DR   eggNOG; KOG0159; Eukaryota.
DR   InParanoid; P15393; -.
DR   PhylomeDB; P15393; -.
DR   Reactome; R-RNO-194002; Glucocorticoid biosynthesis.
DR   Reactome; R-RNO-211976; Endogenous sterols.
DR   SABIO-RK; P15393; -.
DR   UniPathway; UPA00788; -.
DR   PRO; PR:P15393; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0047783; F:corticosterone 18-monooxygenase activity; IBA:GO_Central.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004507; F:steroid 11-beta-monooxygenase activity; IDA:RGD.
DR   GO; GO:0005496; F:steroid binding; IDA:RGD.
DR   GO; GO:0046085; P:adenosine metabolic process; IEP:RGD.
DR   GO; GO:0032342; P:aldosterone biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IBA:GO_Central.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEP:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; IBA:GO_Central.
DR   GO; GO:0034651; P:cortisol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0034650; P:cortisol metabolic process; IBA:GO_Central.
DR   GO; GO:0018894; P:dibenzo-p-dioxin metabolic process; IEP:RGD.
DR   GO; GO:0006704; P:glucocorticoid biosynthetic process; IDA:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:RGD.
DR   GO; GO:0008202; P:steroid metabolic process; TAS:RGD.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR050479; CYP11_CYP27_families.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002399; Cyt_P450_mitochondrial.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   PANTHER; PTHR24279; -; 1.
DR   PANTHER; PTHR24279:SF116; STEROID 11-BETA-MONOOXYGENASE; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00408; MITP450.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Heme; Iron; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion inner membrane; Monooxygenase; Oxidoreductase;
KW   Reference proteome; Steroidogenesis; Transit peptide.
FT   TRANSIT         1..24
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:2738055"
FT   CHAIN           25..499
FT                   /note="Cytochrome P450 11B1, mitochondrial"
FT                   /id="PRO_0000003603"
FT   BINDING         446
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250|UniProtKB:P19099"
FT   VARIANT         127
FT                   /note="R -> C (in strain: Dahl salt-resistant)"
FT   VARIANT         351
FT                   /note="V -> A (in strain: Dahl salt-resistant)"
FT   VARIANT         381
FT                   /note="V -> L (in strain: Dahl salt-resistant)"
FT   VARIANT         384
FT                   /note="I -> L (in strain: Dahl salt-resistant)"
FT   VARIANT         443
FT                   /note="V -> M (in strain: Dahl salt-resistant)"
SQ   SEQUENCE   499 AA;  57459 MW;  19C041F96A673C7E CRC64;
     MALRVTADVW LARPWQCLHR TRALGTTAKV APKTLKPFEA IPQYSRNKWL KMIQILREQG
     QENLHLEMHQ AFQELGPIFR HSAGGAQIVS VMLPEDAEKL HQVESILPHR MPLEPWVAHR
     ELRGLRRGVF LLNGADWRFN RLQLNPNMLS PKAIQSFVPF VDVVARDFVE NLKKRMLENV
     HGSMSINIQS NMFNYTMEAS HFVISGERLG LTGHDLKPES VTFTHALHSM FKSTTQLMFL
     PKSLTRWTST RVWKEHFDSW DIISEYVTKC IKNVYRELAE GRQQSWSVIS EMVAQSTLSM
     DAIHANSMEL IAGSVDTTAI SLVMTLFELA RNPDVQQALR QESLAAEASI VANPQKAMSD
     LPLLRAALKE TLRLYPVGSF VERIVHSDLV LQNYHVPAGT FVIIYLYSMG RNPAVFPRPE
     RYMPQRWLER KRSFQHLAFG FGVRQCLGRR LAEVEMLLLL HHMLKTFQVE TLRQEDMQMV
     FRFLLMPSSS PFLTFRPVS
//
